BB Good human data, but mixed outcomes or surrogate markers. How we grade →Regulatory opinion · 23 studies
Creatine and improvement in cognitive function: Evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA). EFSA Journal. 2024.
- In plain language
- Concluded that a cause-and-effect relationship between creatine and improved cognitive function has not been established; a working memory effect appeared only at 20 g a day for 5 to 7 days.
- Limits
- Evaluated a claim submitted by AlzChem, a creatine maker; judges evidence for an EU label claim, not safety.
- Which of our grades it feeds
- CC Small or few human trials. Promising, not proven. How we grade →Science summary: Creatine and the brain: memory, thinking and sleep loss, and why a regulator said not proven
- Source
- doi.org/10.2903/j.efsa.2024.9100 · PubMed 39564533 · Free full text
Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. We sell some of what we grade.